As of November 2024, Celldex Therapeutics has a market cap of $2.30B. This makes Celldex Therapeutics the world's 4737th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.96B | -9.72% |
2023 | $2.17B | -11.02% |
2022 | $2.44B | 15.35% |
2021 | $2.11B | 120.55% |
2020 | $958.15M | 685.65% |
2019 | $121.96M | -25.67% |
2018 | $164.07M | -92.96% |
2017 | $2.33B | -19.77% |
2016 | $2.90B | -77.42% |
2015 | $12.86B | -14.08% |
2014 | $14.97B | -24.62% |
2013 | $19.86B | 260.80% |
2012 | $5.50B | 158.08% |
2011 | $2.13B | -36.89% |
2010 | $3.38B | -11.78% |
2009 | $3.83B | -41.04% |
2008 | $6.50B | 32.00% |
2007 | $4.92B | -62.69% |
2006 | $13.19B | -28.72% |
2005 | $18.51B | -6.47% |
2004 | $19.79B | -26.64% |
2003 | $26.97B | 142.48% |
2002 | $11.12B | -71.82% |
2001 | $39.47B | -41.67% |
2000 | $67.68B | 178.48% |
1999 | $24.30B | 41.07% |
1998 | $17.23B | -28.21% |
1997 | $23.99B | 50.00% |
1996 | $16.00B | -48.00% |
1995 | $30.76B | 25.00% |
1994 | $24.61B | -67.74% |
1993 | $76.29B | 5.08% |
1992 | $72.60B | -32.95% |
1991 | $108.28B | 274.47% |
1990 | $28.92B | -41.25% |
1989 | $49.22B | 150.00% |
1988 | $19.69B | -33.33% |
1987 | $29.53B | -11.11% |
1986 | $33.22B | - |